Imidazoline receptors: new targets for antihyperglycaemic drugs.

  • N. G. Morgan
  • Published 1999 in Expert opinion on investigational drugs


In both animal models of Type 2 diabetes and in man, it has been evident for many years that certain imidazoline drugs can stimulate insulin secretion and improve glycaemia. This suggests that they may be useful new reagents for use in the management of Type 2 diabetes. However, despite their promise, no imidazoline compound has yet come into clinical use… (More)


Cite this paper

@article{Morgan1999ImidazolineRN, title={Imidazoline receptors: new targets for antihyperglycaemic drugs.}, author={N. G. Morgan}, journal={Expert opinion on investigational drugs}, year={1999}, volume={8 5}, pages={575-84} }